Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 5,862 | 5,023 | 5,092 | 14,344 | 12,702 |
| Cost of Goods | 878 | 889 | 1,401 | 1,109 | 494 |
| Gross Profit | 4,984 | 4,134 | 3,691 | 13,235 | 12,208 |
| Operating Expenses | 18,959 | 14,738 | 11,284 | 11,717 | 11,192 |
| Operating Income | -13,097 | -9,715 | -7,192 | 1,627 | 1,510 |
| Interest Expense | 164 | 160 | 1,314 | 2,094 | 2,131 |
| Other Income | 108 | 193 | 432 | 193 | 825 |
| Pre-tax Income | -13,153 | -9,682 | -8,074 | -274 | 204 |
| Net Income Continuous | -13,153 | -9,682 | -8,074 | -274 | 204 |
| Net Income | $-13,153 | $-9,682 | $-8,074 | $-274 | $204 |
| EPS Basic Total Ops | -0.62 | -0.45 | -0.64 | -0.03 | 0.02 |
| EPS Basic Continuous Ops | -0.62 | -0.45 | -0.64 | -0.03 | 0.02 |
| EPS Diluted Total Ops | -0.62 | -0.45 | -0.64 | -0.03 | 0.02 |
| EPS Diluted Continuous Ops | -0.62 | -0.45 | -0.64 | -0.03 | 0.02 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.45 | -0.56 | 0.05 | 0.02 |
| EBITDA(a) | $-12,890 | $-9,521 | $-7,002 | $1,811 | $1,709 |